> visit Canadian site

 

Live Help

View All Chapters

HOME
PATIENT SERVICES
Call Center
Información - Español
Newly Diagnosed
Find Support
Financial Support
First Connection Request
Stay Informed
Chapter Education Programs
Free Materials
Discussion Boards
Question & Answers
Cancer Centers
DISEASE INFORMATION
Facts & Statistics
Leukemia
Lymphoma
Myeloma
Myelodysplastic Syndromes
Myeloproliferative Disorders
Other Blood Cancers
Childhood Blood Cancers
Treatment & Clinical Trials
National Education Programs
Free Materials
Signs and Symptoms
HOW TO HELP
Donate
Participate in Events
Partner With Us
Send a Free ePostcard
Volunteer with The Leukemia & Lymphoma Society
e-Store and Special Offers
ADVOCACY
Take Action
Campaigns
Resources
About LLS Advocacy
My Advocacy Profile
SCIENCE/PROFESSIONALS
Research Grants
Professional Education
Chapter Professional Education Programs
PubMed
LLS Research & Researchers
Therapy Acceleration Program (TAP)
Cleveland Clinic
LLS
About Us
Contact Us
Free eNews
Careers
Calendar
Press Room
Email:
Password:
Remember Me
Not Yet Registered?



This website is certified by Health On the Net Foundation. Click to verify.
Myeloma: Progress in Treatment and Side Effect Management
Top Stories
Act Now! Urge Your Representatives to Retain Funding for Blood Cancer Education Program
Enter the Ready, Set Give and Get Contest on Facebook Win a $500 Gift Certificate and a $10,000 grant for LLS
LLS CEO Goes Totally Baldacious!
From the TNT Blog: Totally Baldacious Inspiration - Team In Training Coach Jacque
Advocacy Victory in Iowa Iowa Governor Chet Culver signs House File 2075 into law
Jay Duke's Story: A Passion for the Mission
Important Update for Myeloma and Waldenström Macroglobulinemia Patients
Free Booklet: Understanding Drug Therapy and Managing Side Effects
A Sailor Lost to a Tragic Disease From the Offshore Sailing School Blog
LLS Launches Monthly Giving Program Support our commitment to cancer research by becoming an LLS Champion
Medical News:
  • (Research Reports) Study Identifies Key Cause of Chronic Leukemia Progression  More >
  • (Reuters Health) New drug regimens help control Waldenstrom macroglobulinemia  More >
  • (Research Reports) Cells of Aggressive Leukemia Hijack Normal Protein to Grow  More >
Press Releases:
  • (Press Releases) President and CEO of The Leukemia & Lymphoma Society Goes "Totally Baldacious" In Solidarity with Cancer Patients  More >
  • (Press Releases) President and CEO of The Leukemia & Lymphoma Society Going "Totally Baldacious" In Solidarity with Cancer Patients  More >
  News Feeds And Podcasts
CALENDAR

March 23, 2010

National Event		Myeloma: Progress in Treatment and Side Effect Management More >
   More Events


Local Event Chapter
National Event National

back to top
INSIDE STORY
Survey for Patients, Family and Friends We want your feedback - take our booklet survey
More >
DONATE NOW
Help those living with blood cancers by donating to LLS
More >
LIFE MOSAIC
Stories of hope and courage live in Life Mosaic.
more >
VISIT OUR EVENT SITES
HOW TO HELP
planned giving Planned Giving Opportunities Donations as unique as you are. More >

•  Volunteer Your Time
Join our volunteer team and help advance the fight against blood cancers More >

•  Discussion Boards Use our LLS Blood Cancer Discussion Boards to read and post messages with others interested in blood-related cancer issues More >

•  Team In Training®
Run, walk or cycle to make a difference More >
FREE ENEWSLETTERS
Subscribe to one of LLS's Monthly eNewsletters
Name:
Email:
Zip:
eNewsline
LeukemiaLinks
LymphomaLinks
MyelomaLinks
Hematologic Cancer News

  View Samples
















The Leukemia & Lymphoma Society® (LLS) is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world and provides free information and support services.
Need Help? Contact us by email, mail, or call (800) 955-4572 copyright | disclaimer | link | privacy | security
spanish french portuguese